Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm

Area of Science:

• Orthopaedics and Regenerative Medicine
• Diabetic Complications Research
• Stem Cell Biology

Background:

• Diabetic patients exhibit significantly impaired long bone fracture healing, characterized by delayed union, non-union, infection risk, and perioperative complications.
• Underlying causes include aberrant bone mineral density, poor microstructure, altered osteoblast/osteocyte function, increased marrow adiposity, and suppressed progenitor cell differentiation.
• Hyperglycemia negatively impacts bone marrow progenitor cell populations and their osteochondral and vascularization potential, disrupting bone homeostasis.

Approach:

• This review synthesizes existing literature on mesenchymal stem cells (MSCs) for diabetic fracture repair.
• It examines the mechanisms of dysfunctional diabetic fracture healing, including osteoblast dysregulation and the hyperglycemic impact on progenitor cells.
• The review aims to bridge preclinical findings with potential clinical translation for MSC-based therapies.

Key Points:

• Mesenchymal stem cells hold potential for enhancing callus formation and de novo bone generation in hyperglycemic conditions.
• Current clinical research on MSCs in diabetes primarily focuses on metabolic control and beta-cell function, not direct fracture site application.
• The direct application of allogeneic, non-diabetic MSCs at orthopaedic injury sites in diabetics remains largely unexplored.

Conclusions:

• Understanding the detrimental effects of hyperglycemia on bone progenitor cells is crucial for developing effective diabetic fracture repair strategies.
• Further preclinical and clinical investigations are warranted to validate the efficacy of MSC transplantation for orthopedic injuries in diabetic patients.
• Translating preclinical knowledge of MSCs could lead to novel therapeutic approaches for improving fracture healing in the diabetic population.